Share

    


Home / Search Results

Search Results

You searched for:

    Displaying results 21 - 40 of 43
  • «
  • 1
  • 2
  • 3
  • »
Healthcare Futurist Joe Flower opened the #AMCCBS this morning with a quote that may be unexpected from a predictor of scenarios to come: “We don’t need new sights; we need new eyes.” Rather than project a Jetsons-inspired vision of healthcare powered by AI and advanced robotics, Flower began by grounding attendees at the 45th ACCC Annual Meeting & Cancer Center Business Summit in the facts and …
The future of healthcare is at a crossroads. In the past year, the Trump Administration and Congress have made several proposals to address the rising costs of healthcare and drugs­, which have the potential to dramatically affect the landscape of cancer care. Now more than ever, the voices of professionals on the front lines of cancer care are crucial to shaping the direction of future …
Make Your Voice Heard at ACCC Capitol Hill Day BY BLAIR BURNETT Every two years American voters go to the polls to participate in national elections. This fall’s mid-term elections resulted in a major paradigm shift and an entirely different congressional class. With this shake-up in Washington, D.C., new voices are demanding to be heard. Make yours one of them. Each year, in conjunction …
Each year, in conjunction with the ACCC Annual Meeting and Cancer Center Business Summit, ACCC members come to Washington, D.C., for our Capitol Hill Day. Across the board, these members tell us how much they’ve enjoyed this unique opportunity to meet in small groups, or even one-on-one, with their legislators and congressional staffers to talk about challenges—and successes—at their cancer programs …
November 26, 2018 The Honorable Gus Bilirakis U.S. House of Representatives 2112 Rayburn House Office Building Washington, DC 20515 The Honorable Ben Ray Lujan U.S. House of Representatives 2231 Rayburn House Office Building Washington, DC 20515 Dear Representative Bilirakis and Representative Lujan, On behalf of the undersigned organizations, representing …
In September 2018, the Association of Community Cancer Centers (ACCC) submitted comments to the Centers for Medicare & Medicaid Services (CMS) in response to both the 2019 Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules. The arrival of autumn signals seasonal changes, but one constant is the policy implications of the proposed Medicare payment rules …
On October 25, 2018, President Trump addressed a campaign promise ahead of the heavily contested mid-term elections regarding his administration’s continued drug pricing reform efforts. Healthcare leadership under the Trump administration unveiled a three-prong plan using the Center for Medicare and Medicaid Innovation (CMMI) to test three ways to lower the costs of drugs, aimed largely at Medicare …
Autumn signals seasonal changes, but one constant is the annual assessment of the policy implications of the proposed Medicare payment rules for the upcoming calendar year. In this 2019 rule-making cycle, access to care and the overall reimbursement and healthcare delivery landscape have the potential to undergo a drastic shift. In September ACCC submitted comments to both the 2019 Physician Fee Schedule …
Medicare Advantage Appeal Outcomes and Audit Findings Raise Concerns About Service and Payment Denials (OEI-09-16-00410; 09/18) U.S. Department of Health and Human Services Office of Inspector General Medicare Advantage Appeal Outcomes and Audit Findings Raise Concerns About Service and Payment Denials Daniel R. Levinson Inspector General …
On July 25, 2018, the Centers for Medicare & Medicaid Services (CMS) released the CY 2019 Outpatient Prospective Payment System (OPPS) proposed rule, and we are seeing several efforts to continue the push towards “site neutral” payments in off-campus provider-based departments (PBDs). This rule was issued weeks after the CY 2019 Physician Fee Schedule (PFS) proposed rule, and the atypical lag time …
Summer in Washington, D.C., has always had a strong correlation to heated political activity. As the temperatures climb this month, proposed policies to reform the way the Centers for Medicare & Medicaid Services (CMS) pays providers for drugs and services are heating up as well. On July 12, 2018, CMS released its CY 2019 proposed Physician Fee Schedule rule, putting forward some significant proposals …
As policymakers seek legislative solutions to the opioid crisis, it is imperative to recognize that broad opioid bills that do not specifically address the issue of different types of pain run the risk of harming our vulnerable cancer patient population in terms of adequately treating cancer-related pain.
Healthcare stays in flux as Congress passed an omnibus spending bill this past Friday, March 23, funding the federal government through September 2018. While many healthcare provisions made their way into the budget, including increased funding for the opioid epidemic, the National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC), there was no inclusion of a market …
Implications of the Budget Deal & the President’s FY2019 Budget for Oncology After another brief government shutdown, Congress passed the Bipartisan Budget Act of 2018 on Friday, February 9. Healthcare provisions embedded within this legislation will have an important impact on clinicians and patients. Of note, the two-year budget deal raises budget caps by $300 billion, funds the federal government …
All eyes are on Congress in recent months with Affordable Care Act repeal and tax reform, but the real action—and consequential reimbursement decisions for ACCC cancer programs—is happening on the regulatory side.
In August 2015 the Health Resources and Services Administration (HRSA) released its much-anticipated “mega-guidance” on the 340B Drug Pricing Program, proposing new limits on the program but stopping short of a complete overhaul, prompting mixed reviews from stakeholders.
The last few months have brought big changes to Washington, D.C. The 2014 midterm elections dealt a sweeping victory to Republicans in Congress, giving the party a 54-seat majority in the Senate and its biggest majority in the House since 1928.
While the 340B Program has grown, and reform has been widely debated by policymakers over the past decade, CMS’ rule proposes to fundamentally alter the program (notably a program that is not within CMS’ purview).
On May 4, 2017, the U.S. House of Representatives narrowly passed the American Health Care Act (AHCA), a bill that would repeal and replace key portions of the Affordable Care Act (ACA). The bill now heads to the Senate, where it faces significant concerns over the projected decrease in coverage and increase in cost, and will likely undergo a substantial re-write. While the bill faces …
In 2016, we saw the Obama Administration finalize regulations around sweeping physician payment reform in Medicare, oncology practices nationwide navigate the first year of the Oncology Care Model (OCM), policymakers try—and fail—to push through drug pricing reform with a national mandatory demonstration program, the 21st Century Cures Act signed into law, and the drug pricing debate hit a fever …
    Displaying results 21 - 40 of 43
  • «
  • 1
  • 2
  • 3
  • »